Optimapharm
Optima neuro suite bg
OptimaNeuro Suite - neurology CRO and clinical trial platform
Partnered on
81
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
82
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Approved Neurological Therapies

OptimaNeuro Suite introduces a fully integrated neurology Full Service CRO ecosystem that brings together leading neurology experts, experienced research sites, advanced digital tools, and engaged patient communities into one seamless platform. Designed to navigate the complexity of neurological studies, it streamlines operations, accelerates study start-up, strengthens evidence generation, and supports meaningful patient engagement. By connecting every stakeholder across the neurology research journey, OptimaNeuro Suite turns scientific and operational complexity into coordinated, insight-driven progress

75+ Neurology Projects
24,000+ Subjects Enrolled
Distribution of Optimapharm rare disease projects by therapeutic area

Strategic Advisory Board

Dr. Pavle Vukojević

Dr. Pavle Vukojević

Chief Medical Officer

Dr. Roger E. Morgan, MD, FACS

Dr. Roger E. Morgan, MD, FACS

Medical Advisor, Neurology

Dr. Stephen Murray

Dr. Stephen Murray

Medical Advisor, CNS

Fuentsanta Bellvis Bataller

Fuentsanta Bellvis Bataller

Clinical Imaging, Oncology

Patient Advisory Board

Optimapharm has established a dedicated Patient Advisory Board, which we actively collaborate with and support to ensure patients' perspectives are reflected throughout development. By embedding their voice into clinical trial protocols and study execution, we help shape research that is more accessible, meaningful and aligned with the needs of those it aims to serve

Optimapharm Patient Advisory Board members
Sandra Silva-Arrieta, Patient Advisory Board Lead at Optimapharm

We Proudly Support

Alzheimer's Society - patient advocacy partner

Site & Patient Referral Networks

Optimapharm strategically partners with diverse site networks, including community-based recruitment organisations, site management organisations, and leading hospital systems, to deliver faster and more seamless study execution. With twice the reach across North America and Europe compared with the average mid-sized CRO, we expand access to patients where they live and receive care, enabling broader enrolment and real-world representation. These collaborative partnerships drive accelerated start-up, stronger referral pathways and a consistently high-performing site experience.

Hybrid and decentralised rare disease trial delivery network
Accelerated study start-up through site network partnerships
Patient reach compared with the average mid-sized CRO

2xThe reach of the average mid-sized CRO in North America and Europe

Healthcare professional supporting a clinical trial patient

Accelerating delivery through patient reach and expanded access to regulatory frameworks

Data Visualisations

BI WIZARD analytics dashboard

BI Wizard is our custom-built analytics solution, developed and powered by Microsoft Power BI. It leverages Power BI's robust business intelligence platform to visualise data, share insights, and provide interactive dashboards and reports. With BI Wizard, both Optimapharm and our sponsors can easily explore and interact with data, supporting informed, data-driven decision-making on all sides

Operational Insights

Example Report (Enrolment)
Example BI WIZARD enrolment report

Patient Profiling

Example Report (Blood Pressure)
Example BI WIZARD patient profiling report - blood pressure

Endpoint & Outcome Measures

Central Imaging

Central Imaging
✓Imaging endpoints assessment and centralized reads
✓End-to-end imaging platform
✓AI-powered technology to extract exploratory imaging endpoints
STRATEGIC PARTNER
Quibim - central imaging strategic partner

Central Laboratory

Central Laboratory
✓CAP Certified global laboratories
✓Health Institution for LDT/IVDR
✓PBMC Network
Large range of Broad Biomarker Capabilities
STRATEGIC PARTNER
mlm medical labs - central laboratory strategic partner

Resource Hub